17-45136712-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001135705.3(ACBD4):c.230G>T(p.Gly77Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,613,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001135705.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACBD4 | NM_001135705.3 | c.230G>T | p.Gly77Val | missense_variant | 4/10 | ENST00000321854.13 | NP_001129177.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACBD4 | ENST00000321854.13 | c.230G>T | p.Gly77Val | missense_variant | 4/10 | 1 | NM_001135705.3 | ENSP00000314440.8 | ||
ACBD4 | ENST00000591859.5 | c.230G>T | p.Gly77Val | missense_variant | 6/12 | 1 | ENSP00000465610.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152226Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000401 AC: 10AN: 249418Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135366
GnomAD4 exome AF: 0.0000486 AC: 71AN: 1461716Hom.: 0 Cov.: 33 AF XY: 0.0000564 AC XY: 41AN XY: 727158
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2024 | The c.230G>T (p.G77V) alteration is located in exon 6 (coding exon 3) of the ACBD4 gene. This alteration results from a G to T substitution at nucleotide position 230, causing the glycine (G) at amino acid position 77 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at